Sotagliflozin: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 1023, doi. 10.1007/s40265-019-01146-5
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2019 AND VI 79 AND IP 9
Results: 9
1
2
Erdafitinib: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 1017, doi. 10.1007/s40265-019-01142-9
- By:
- Publication type:
- Article
3
Siponimod: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 1009, doi. 10.1007/s40265-019-01140-x
- By:
- Publication type:
- Article
4
Nutritional Psychiatry: From Concept to the Clinic.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 929, doi. 10.1007/s40265-019-01134-9
- By:
- Publication type:
- Article
5
Tiotropium/Olodaterol: A Review in COPD.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 997, doi. 10.1007/s40265-019-01133-w
- By:
- Publication type:
- Article
6
Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 969, doi. 10.1007/s40265-019-01132-x
- By:
- Publication type:
- Article
7
Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 903, doi. 10.1007/s40265-019-01126-9
- By:
- Publication type:
- Article
8
Mechanism of Action and Clinical Attributes of Auryxia<sup>®</sup> (Ferric Citrate).
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 957, doi. 10.1007/s40265-019-01125-w
- By:
- Publication type:
- Article
9
Medical Management of Cushing's Syndrome: Current and Emerging Treatments.
- Published in:
- Drugs, 2019, v. 79, n. 9, p. 935, doi. 10.1007/s40265-019-01128-7
- By:
- Publication type:
- Article